期刊文献+

生长抑素及类似物在甲状腺相关眼病中的应用进展

Progress in applications of somatostin and its analogues in thyroid associated ophthalmopathy
原文传递
导出
摘要 生长抑素及其类似物是一种调节性多肽,其毒副作用小。近年来发现新的生长抑素类似物,如长效生长抑素类似物和合成的SOM230等,患者耐受性好,越来越广泛的应用于评价和治疗甲状腺相关眼病。通过文献检索评价生长抑素及类似物在甲状腺相关眼病中的基础和临床应用。 Somatostatin and its analogues are a kind of regulatory peptides, their side effects are lower. Newly developed somatostatin analogues,such as some long-acting somatostatin analogues and a synthetic SOM230,have been developed and they have small side effects and good tolerance are well tolerated in the patients with TAO. They are also used widely in the evaluation and treatment of thyroid associated ophthalmopathy in recent years. The literatures are reviewed for evaluation of basic studies and clinical applications of somatostatin and its analogus in treatment of thyroid-associated ophthalmopathy.
出处 《中国热带医学》 CAS 2009年第11期2192-2193,2208,共3页 China Tropical Medicine
关键词 生长抑素 生长抑素类似物 甲状腺相关性眼病 Somatostatin,somatostatin analogues Thyroid-associated ophthalmopathy
  • 相关文献

参考文献16

  • 1L. Bartalena and M. L Tanda. Graves' Ophthalmopathy[J] . N. Engl. J. Med.March 5,2009,360(10) : 994-1001.
  • 2Bartalena L,Baldeschi L,Dickinson A,et al. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. European Group on Graves' Orbitopathy (EUGOGO) [ J ]. Eur J Endocrinol, 2008,158 ( 3 ) : 273 -285.
  • 3Lee HB, Rodgers IR, Woog JJ. Evaluation and management of Graves' orbitopathy[ J ]. Otolaryngol Clin North Am, 2006,39 ( 5 ) : 923-942, vi.
  • 4Salvi M,Vannucchi G,Campi I,et al . Treatment of Graves] disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab:an open study [J] . Eur J Endocrinol 2007,156: 33-40.
  • 5Armani C, Catalani E, Balbarini A, et al. Expression, pharmacology, and functional role of somatostatin receptor subtypesl and 2 in human macrophages [ J ]. J Leukoc Biol,2007,81 ( 3 ) : 845 -855.
  • 6Irina Cozma,Lei Zhang,James Uddin,et al. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathic orbits: relevance to novel analogs [J]. Am J Physiol Endocrinol Metab,293: E1630-E 1635,2007.
  • 7Cozma I,Zhang L,Uddin J,et al . Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs [J] . Am J Physiol Endocrinol Metab. 2007,293 (6) : E1630-5. Epub, 2007 Sep 11.
  • 8G. E. Krassas,N. Pontikides,T. Kaltsal,et al. Free and Total Insulin- Like Growth Factor (IGF)-Ⅰ,-Ⅱ,and IGF Binding Protein-l,-2, and -3 Serum Levels in Patients with Active Thyroid Eye Disease [J]. J Clinical Endocrinology & Metabolism, 88( 1 ):132-135.
  • 9Krassas GE, Gogakos A . thyroid associated orbitopathy in juvenile Graves' disease--clinical,endocrine and therapeutic aspects [J] . J Pediatr Endocrinol Metab, 2006,19 (10) : 1193-1206.
  • 10Gormau CA.Clever is not enough: NOSPECS is form in search of function[J] . Thyroid, 1991,1:353-355.

二级参考文献1

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部